Mantle cell lymphoma. (Wikipedia)
New Israeli-Developed Therapy Seeks to Heal Incurable Blood Cancer
Tel Aviv University (TAU) researchers have developed an innovative system that may treat mantle cell lymphoma (MCL).
A recently published study revealed that using RNA therapy can successfully stop the reproduction of cancer-related protein in white blood cells in both animals and samples from human mantle cell lymphoma (MCL) patients.
The research was led by Prof. Dan Peer of TAU’s Department of Cell Research and Immunology, and conducted by TAU Ph.D. students Shiri Weinstein and Itai Toker, in collaboration with Prof. Pia Raanani of Rabin Medical Center and Prof. Arnon Nagler of Sheba Medical Center.
MCL is known as the most aggressive blood cancer, and affects 3,000 Americans every year. The cancer has a survival rate of five to seven years after diagnosis, with limited systemic therapeutic drug therapies available.
By: JNS.org
Do You Support Israel?
Want to do something important for Israel? Make a donation to United with Israel, and help to educate and inspire millions around the world to support Israel too!
Now more than ever, Israel needs your help to fight the battle of public opinion. Israel's enemies are using social media to incite brutal terror against innocent civilians. We need your help to fight back! Every day, we teach the truth about Israel to millions of people around the world.
In addition, United with Israel contributes to vital causes like building bomb shelters to protect Israeli citizens. Donations from true friends of Israel like you make this possible, so please show your support today!
No comments:
Post a Comment